The Baldwin Insurance Group, Inc. (BWIN)
NASDAQ: BWIN · Real-Time Price · USD
32.79
+1.21 (3.83%)
Aug 12, 2025, 4:00 PM - Market closed
Ligand Pharmaceuticals Analyst Ratings
Total Analysts
8
Consensus Rating
Buy
Price Target
$44.00
Upside
+34.19%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Raymond James | Raymond James | Strong Buy → Buy Downgrades $48 → $40 | Strong Buy → Buy | Downgrades | $48 → $40 | +21.99% | Aug 7, 2025 |
Wells Fargo | Wells Fargo | Sell Maintains $34 → $36 | Sell | Maintains | $34 → $36 | +9.79% | Jul 10, 2025 |
BMO Capital | BMO Capital | Buy Maintains $51 → $50 | Buy | Maintains | $51 → $50 | +52.49% | Jun 13, 2025 |
Jefferies | Jefferies | Hold Maintains $41 → $42 | Hold | Maintains | $41 → $42 | +28.09% | Apr 11, 2025 |
Wells Fargo | Wells Fargo | Sell Maintains $33 → $34 | Sell | Maintains | $33 → $34 | +3.69% | Apr 10, 2025 |
JP Morgan | JP Morgan | Buy → Hold Downgrades $39 → $45 | Buy → Hold | Downgrades | $39 → $45 | +37.24% | Apr 8, 2025 |
BMO Capital | BMO Capital | Buy Initiates $53 | Buy | Initiates | $53 | +61.63% | Mar 27, 2025 |
JP Morgan | JP Morgan | Buy Maintains $46 → $39 | Buy | Maintains | $46 → $39 | +18.94% | Feb 26, 2025 |
Wells Fargo | Wells Fargo | Sell Maintains $38 → $33 | Sell | Maintains | $38 → $33 | +0.64% | Feb 26, 2025 |
Wells Fargo | Wells Fargo | Sell Maintains $41 → $38 | Sell | Maintains | $41 → $38 | +15.89% | Jan 14, 2025 |
Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Buy Maintains $50 → $49 | Buy | Maintains | $50 → $49 | +49.44% | Jan 10, 2025 |
JP Morgan | JP Morgan | Buy Maintains $47 → $46 | Buy | Maintains | $47 → $46 | +40.29% | Jan 3, 2025 |
Wells Fargo | Wells Fargo | Hold → Sell Downgrades $43 → $41 | Hold → Sell | Downgrades | $43 → $41 | +25.04% | Dec 11, 2024 |
Wells Fargo | Wells Fargo | Hold Maintains $46 → $43 | Hold | Maintains | $46 → $43 | +31.14% | Nov 5, 2024 |
William Blair | William Blair | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Oct 17, 2024 |
JP Morgan | JP Morgan | Buy Maintains $45 → $54 | Buy | Maintains | $45 → $54 | +64.68% | Oct 10, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.